levofloxacin has been researched along with tryptamine in 1 studies
Studies (levofloxacin) | Trials (levofloxacin) | Recent Studies (post-2010) (levofloxacin) | Studies (tryptamine) | Trials (tryptamine) | Recent Studies (post-2010) (tryptamine) |
---|---|---|---|---|---|
4,346 | 581 | 2,209 | 844 | 2 | 221 |
Protein | Taxonomy | levofloxacin (IC50) | tryptamine (IC50) |
---|---|---|---|
Vif | Human immunodeficiency virus 1 | 1.66 | |
Tat | Human immunodeficiency virus 1 | 11.753 | |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | Homo sapiens (human) | 1.66 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gozalbes, R; Pineda-Lucena, A | 1 |
1 other study(ies) available for levofloxacin and tryptamine
Article | Year |
---|---|
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |